Commentary

Reexamination of Field-Directed Therapy for Actinic Keratosis [editorial]

Berman et al recently published a 2-part series exploring the role of field-directed therapy in the management of actinic keratosis (AK). As a member of the Cutis Editorial Board, I applaud this comprehensive and thoughtful body of work. Nonetheless, I think it is worth a brief critical reexamination of several specific issues regarding the treatment of AK.

Listen to Dr. Rosen's audiocast on field-directed therapy for actinic keratosis here.


 

Recommended Reading

Economic Forecast: Rough Road Ahead for Dermatologists
MDedge Dermatology
RUC Predicted to Slash AK Reimbursement
MDedge Dermatology
Photodamage Effectively Treated With Quasi-Ablative Approach
MDedge Dermatology
BRAF-Plus-MEK Inhibition Slows Melanoma
MDedge Dermatology
Eyeglasses May Offer Periocular AK Protection
MDedge Dermatology
Let Lip Defect Size Drive Treatment
MDedge Dermatology
What Is the Role of Field-Directed Therapy in the Treatment of Actinic Keratosis? Part 1: Overview and Investigational Topical Agents
MDedge Dermatology
What Is the Role of Field-Directed Therapy in the Treatment of Actinic Keratosis? Part 2: Commonly Used Field-Directed and Lesion-Directed Therapies
MDedge Dermatology
Treatment of Actinic Keratoses
MDedge Dermatology
Cosmetic Clinical Indications for Photodynamic Therapy
MDedge Dermatology